The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Telander, D. G.
Right arrow Articles by Mueller, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Telander, D. G.
Right arrow Articles by Mueller, D. L.
The Journal of Immunology, 1999, 162: 1460-1465.
Copyright © 1999 by The American Association of Immunologists

Evidence for Repression of IL-2 Gene Activation in Anergic T Cells1

David G. Telander, Erika-Nell Malvey and Daniel L. Mueller2

Department of Medicine and Center for Immunology, University of Minnesota Medical School, Minneapolis, MN 55455

The induction of clonal anergy in a T cell inhibits IL-2 secretion because of the development of a proximal signal transduction defect. Fusion of anergic murine T cells to human Jurkat T leukemia cells and formation of heterokaryons failed to result in a complementation of this signaling defect and restoration of murine IL-2 mRNA inducibility. Instead, signal transduction to the human IL-2 gene became disrupted. Heterokaryons formed by the fusion of anergic murine T cells to normal murine T cells also failed to accumulate intracellular IL-2 protein in response to stimulation either with the combination of CD3 and CD28 mAbs or with ionomycin plus a protein kinase C-activating phorbol ester. The results argue against a loss-of-function signaling defect as the sole basis for clonal anergy induction and document the presence of a dominant-acting repressor molecule that inhibits signal transduction to the IL-2 gene within viable anergic T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. M. Thomas, N. Chunder, C. Chen, S. E. Umetsu, S. Winandy, and A. D. Wells
Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes
J. Immunol., December 1, 2007; 179(11): 7305 - 7315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bostik, E. S. Noble, S. T. Stephenson, F. Villinger, and A. A. Ansari
CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation
J. Immunol., June 15, 2007; 178(12): 7720 - 7729.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Bandyopadhyay, M. Dure, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macian
Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells
Blood, April 1, 2007; 109(7): 2878 - 2886.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Veldman, A. Pahl, S. Beissert, W. Hansen, J. Buer, D. Dieckmann, G. Schuler, and M. Hertl
Inhibition of the transcription factor foxp3 converts desmoglein 3-specific type 1 regulatory T cells into th2-like cells.
J. Immunol., March 1, 2006; 176(5): 3215 - 3222.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Su, R. J. Creusot, E. M. Gallo, S. M. Chan, P. J. Utz, C. G. Fathman, and J. Ermann
Murine CD4+CD25+ Regulatory T Cells Fail to Undergo Chromatin Remodeling Across the Proximal Promoter Region of the IL-2 Gene
J. Immunol., October 15, 2004; 173(8): 4994 - 5001.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Ohkusu-Tsukada, N. Tominaga, H. Udono, and K. Yui
Regulation of the Maintenance of Peripheral T-Cell Anergy by TAB1-Mediated p38{alpha} Activation
Mol. Cell. Biol., August 15, 2004; 24(16): 6957 - 6966.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Dillon, V. Karpitski, S. A. Wetzel, D. C. Parker, A. S. Shaw, and P. J. S. Stork
Ectopic B-Raf Expression Enhances Extracellular Signal-regulated Kinase (ERK) Signaling in T Cells and Prevents Antigen-presenting Cell-induced Anergy
J. Biol. Chem., September 19, 2003; 278(38): 35940 - 35949.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
M. Li, C. Torres, C. Acuna-Castillo, R. Walter, E. M. Gardner, D. M. Murasko, and F. Sierra
Defect in ERK2 and p54JNK Activation in Aging Mouse Splenocytes
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): B41 - 47.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
T. L. Vanasek, A. Khoruts, T. Zell, and D. L. Mueller
Antagonistic Roles for CTLA-4 and the Mammalian Target of Rapamycin in the Regulation of Clonal Anergy: Enhanced Cell Cycle Progression Promotes Recall Antigen Responsiveness
J. Immunol., November 15, 2001; 167(10): 5636 - 5644.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. de Visser, T. A. Cordaro, H. W. H. G. Kessels, F. H. Tirion, T. N. M. Schumacher, and A. M. Kruisbeek
Low-Avidity Self-Specific T Cells Display a Pronounced Expansion Defect That Can Be Overcome by Altered Peptide Ligands
J. Immunol., October 1, 2001; 167(7): 3818 - 3828.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Finch, P. E. Fields, and P. D. Greenberg
A Transcriptional Block in the IL-2 Promoter at the -150 AP-1 Site in Effector CD8+ T Cells
J. Immunol., June 1, 2001; 166(11): 6530 - 6536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bostik, A. E. Mayne, F. Villinger, K. P. Greenberg, J. D. Powell, and A. A. Ansari
Relative Resistance in the Development of T Cell Anergy in CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys
J. Immunol., January 1, 2001; 166(1): 506 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Attinger, H. Acha-Orbea, and H. R. MacDonald
Cutting Edge: Cell Autonomous Rather Than Environmental Factors Control Bacterial Superantigen-Induced T Cell Anergy In Vivo
J. Immunol., August 1, 2000; 165(3): 1171 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Bouhdoud, P. Villain, A. Merzouki, M. Arella, and C. Couture
T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide
J. Virol., March 1, 2000; 74(5): 2121 - 2130.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. D. Powell, C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz
The -180 Site of the IL-2 Promoter Is the Target of CREB/CREM Binding in T Cell Anergy
J. Immunol., December 15, 1999; 163(12): 6631 - 6639.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.